Interventional Trial of Vitamin D Deficiency in the Patients of General Departments
|ClinicalTrials.gov Identifier: NCT00640237|
Recruitment Status : Unknown
Verified March 2008 by Rambam Health Care Campus.
Recruitment status was: Recruiting
First Posted : March 21, 2008
Last Update Posted : March 21, 2008
|Condition or disease||Intervention/treatment||Phase|
|Vitamin D Deficiency||Dietary Supplement: Alpha-D3||Phase 3|
Today vitamin D is thought to be one of the most important vitamins in the human body. It's made in the skin during the sun expose, so it must be sufficient in so sunny countries as Israel. Although many old people in our country suffer from vitamin d deficiency which bring them to recurrent falls, osteoporotic fractures and physical disability. This problem is still underestimated by health authorities in different countries.
In this study we will examine the vitamin D state of the therapeutic patient older than 65 year including their physical self-estimation, muscle strength measurement and gait-and-balance tests. Then, according to the resent studies, we will treat the patients in the interventional group with two large doses of vitamin D during a month. After that we will compere their health and physical state with the patients treated in the out-hospital department.
So we will try to find a useful approach to treat the vitamin D deficiency during the hospitalization.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||300 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Vitamin D Deficiency in the Elder Patients of General Departments and Its Treatment During the Hospitalization|
|Study Start Date :||March 2008|
|Estimated Primary Completion Date :||July 2008|
|Estimated Study Completion Date :||August 2008|
Arm 1 - the patients will receive two large doses of vitamin D.
Dietary Supplement: Alpha-D3
We will use the vitamin alpha-D3 drops of CTS pharmaceutical firm , that contains 5000 IU in ml. Every patient in the interventional group will receive two dose of 100000 IU (20 ml)vitamin alpha-D3 within a month period.
Other Name: 25(OH)-D3
No Intervention: 2
Arm 2 - the patients vitamin D status will be checked during the hospitalization and they will receive the recommendation to treat the vitamin D deficiency in the out-patient department.
- vitamin D status [ Time Frame: two month ]
- physical performance, health conditions, arm strength, gait and balance state. [ Time Frame: two month ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00640237
|Contact: Ish-Shalom Sofia, Professorfirstname.lastname@example.org|
|Contact: Nodelmam Marina, MDemail@example.com|
|Rambam Health Care Campus||Recruiting|
|Sub-Investigator: Nodelman Marina, MD|
|Principal Investigator:||Ish-Shalom Sofia, Professor||Rambam Health Care Campus|